Prenatal diagnosis of craniomaxillofacial malformations: a characterization of phenotypes in trisomies 13, 18, and 21 by ultrasound and pathology.
OBJECTIVE
To determine the relationship between trisomies 13, 18, and 21 and craniofacial malformations detected by prenatal sonography.


METHODS
During a 29-year period (1976 through 2004), prenatal sonographic findings of 69 fetuses with trisomy 13; 171 fetuses with trisomy 18; 302 fetuses with trisomy 21; and 17 fetuses with other trisomies were evaluated retrospectively, after fetal karyotype identification. Sonographic findings were compared with autopsy results in 209 patients (trisomy 13, n=39; trisomy 18, n=64; and trisomy 21, n=106).


RESULTS
For trisomy 13, cleft deformities were detected prenatally in 65.2%, and of the 39 cases with pathological information, 76.9% were found to have a cleft deformity. Ocular and orbital abnormalities were found in 28%. Malformations of the jaws and abnormal profiles were more frequently diagnosed postnatally than prenatally. For trisomy 18, abnormal profiles (41.5%) and ear abnormalities (5.3%) were the most noticeable ultrasound markers, next to abnormalities of the neurocranium (36.8%) and cranial bone configuration (21.6%). Dysmorphisms of the eye, ear, or nose were detected more frequently in autopsy cases. For trisomy 21, ultrasound showed an aberrant shape of the skull in 14.2% of fetuses. In general, the ocular-orbital and nasal abnormalities in fetuses with trisomy 18 or 21 were more evident in pathological examination than in prenatal ultrasound imaging.


CONCLUSIONS
Facial anomalies are common in the major trisomies, and their prenatal sonographic identification should be improved. The above-mentioned facial anomalies provide sufficient reason to consider performing cytogenic evaluation.
Ettema
A M
AM
Department of Oral and Maxillofacial Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Wenghoefer
M
M
Hansmann
M
M
Carels
C E L
CE
Borstlap
W A
WA
Bergé
S J
SJ
D000328:Adult; D000649:Amniocentesis; D001344:Autopsy; D002901:Chromosomes, Human, 13-15 / Q000000981:diagnostic imaging / Q000235:genetics*; D002902:Chromosomes, Human, 16-18 / Q000000981:diagnostic imaging / Q000235:genetics*; D002904:Chromosomes, Human, 21-22 and Y / Q000000981:diagnostic imaging / Q000235:genetics*; D019465:Craniofacial Abnormalities / Q000000981:diagnostic imaging* / Q000235:genetics* / Q000473:pathology; D005260:Female; D005819:Genetic Markers; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007621:Karyotyping; D008297:Male; D008423:Maternal Age; D019767:Maxillofacial Abnormalities / Q000000981:diagnostic imaging* / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D012189:Retrospective Studies; D012886:Skull / Q000002:abnormalities; D014314:Trisomy / Q000473:pathology*; D016216:Ultrasonography, Prenatal
D005819:Genetic Markers